How much is Slade Health worth in 2026?

Slade Health has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Slade Health raised?

Slade Health has raised N/A in total funding across 1 funding rounds.

Slade Health

Pharmaceuticals

Slade Health valuation and funding history | Last updated: September 1, 2016 | 1 funding rounds

Current Valuation

N/A

As of September 1, 2016

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Sep 2016

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 1, 2016	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Slade Health is currently valued at N/A as of September 1, 2016.

Track Slade Health Valuation Updates

Get notified when Slade Health raises new funding or valuation changes

Explore More Data

Detailed analysis for Slade Health

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Slade Health's valuation history, funding rounds, and growth metrics.

No credit card required

What is Slade Health Worth in 2026?

Slade Health is a leading private company in the Pharmaceuticals sector. Track Slade Health's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Slade Health Valuation is Determined

Private company valuations like Slade Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.